Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Proliferating cell nuclear antigen (PCNA) is a nuclear protein crucial for active cell cycle progression.
• PCNA expression levels can indicate cellular proliferation rates.
• Renal cell carcinoma (RCC) is a complex malignancy where understanding proliferation markers is vital for prognosis.

Purpose of the Study:

• To evaluate the expression of PCNA in renal cell carcinoma (RCC) tissues.
• To determine the correlation between PCNA expression and clinicopathological parameters of RCC.
• To assess the prognostic value of PCNA expression in RCC patients.

Main Methods:

• Immunohistochemical analysis of PCNA expression using the PC-10 monoclonal antibody.
• Quantification of PCNA-index (percentage of positively stained nuclei) in 279 RCC tumor samples.
• Statistical analysis to compare PCNA-index with tumor grade, clinical stage, DNA ploidy, and patient survival.

Main Results:

• Tumor PCNA-index (mean 4.9%) was significantly higher in RCC compared to normal kidney cortex (p < 0.001).
• PCNA-index significantly differed between tumor grades and between diploid and aneuploid tumors (p = 0.002).
• Low PCNA-index (< 3.5%) was associated with a significant survival advantage for RCC patients (p = 0.019).

Conclusions:

• PCNA expression is a quantifiable marker in renal cell carcinoma.
• PCNA-index correlates with tumor grade and DNA ploidy.
• PCNA expression serves as a valuable additional prognostic parameter for renal cell carcinoma patients.